newsfilter
← Latest News
PR Newswire·

LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference

LEXINGTON, Mass., March 23, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview at th